August 29, 2016 3:38 AM ET

Biotechnology

Company Overview of VistaGen Therapeutics, Inc.

Executive Profile

Jerry B. Gin Ph.D., MBA

Director and Member of Audit Committee, VistaGen Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
73$181,103

Background

Dr. Jerry B. Gin, Ph.D., MBA is a co-founder and Chief Executive Officer of Nuvora, Inc. Dr. Gin is also co-founder and Chairman of Livionex. Dr. Gin has over 45 years of experience in the healthcare industry, focusing on founding and developing pharmaceutical, diagnostic and biotechnology companies. He Co-founded Oculex Pharmaceuticals, Inc., in 1992 and served as its President since 1992. Dr. Gin served as the Chief Executive Officer of Oculex Pharmaceuticals, Inc., ...

Corporate Headquarters

343 Allerton Avenue
South San Francisco, California 94080

United States

Phone: 650-577-3600
Fax: 888-482-2602

Board Members Memberships

Director
2016-Present
Director and Member of Audit Committee

Education

PhD
University of California Berkeley
BS
The University of Arizona
MBA
Loyola University Maryland

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Calculated Compensation$181,103
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact VistaGen Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.